Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging: Does a US Food and Drug Administration alert influence practice patterns in CKD?

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)427-430
Number of pages4
JournalAmerican Journal of Kidney Diseases
Volume56
Issue number3
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Adverse Drug Reaction Reporting Systems
Nephrogenic Fibrosing Dermopathy
Physicians' Practice Patterns
Gadolinium
Kidney Diseases
United States Food and Drug Administration
Contrast Media
Chronic Disease
Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Nephrology
  • Medicine(all)

Cite this

@article{e0b8d14a3a5d49508c8ade4cbb6c00b2,
title = "Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging: Does a US Food and Drug Administration alert influence practice patterns in CKD?",
author = "Martin, {Diego R}",
year = "2010",
doi = "10.1053/j.ajkd.2010.07.001",
language = "English (US)",
volume = "56",
pages = "427--430",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging

T2 - Does a US Food and Drug Administration alert influence practice patterns in CKD?

AU - Martin, Diego R

PY - 2010

Y1 - 2010

UR - http://www.scopus.com/inward/record.url?scp=77956213418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956213418&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2010.07.001

DO - 10.1053/j.ajkd.2010.07.001

M3 - Article

C2 - 20728788

AN - SCOPUS:77956213418

VL - 56

SP - 427

EP - 430

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 3

ER -